Oropharynx carcinoma: irradiation aloneversusinduction chemotherapy plus irradiation—5 year results
| Autor: | Garand G, P Beutter, O Le Floch, A. Reynaud-Bougnoux, Gilles Calais |
|---|---|
| Rok vydání: | 1990 |
| Předmět: |
medicine.medical_specialty
5 year survival rate Vindesine medicine.medical_treatment Bleomycin Gastroenterology chemistry.chemical_compound Actuarial Analysis Internal medicine Antineoplastic Combined Chemotherapy Protocols medicine Carcinoma Humans Combined Modality Therapy Radiology Nuclear Medicine and imaging Oropharynx Carcinoma Radionuclide Imaging Retrospective Studies business.industry Remission Induction Induction chemotherapy Pharyngeal Neoplasms Retrospective cohort study General Medicine Middle Aged medicine.disease Radiation therapy Oropharyngeal Neoplasms chemistry Vincristine Carcinoma Squamous Cell Fluorouracil Cisplatin Nuclear medicine business |
| Zdroj: | The British Journal of Radiology. 63:340-345 |
| ISSN: | 1748-880X 0007-1285 |
| DOI: | 10.1259/0007-1285-63-749-340 |
| Popis: | Induction chemotherapy (CT) has demonstrated overall response rates of 80% for oropharynx carcinomas, but no overall survival benefit has been reported. In order to determine the value of induction CT for such patients, we conducted a retrospective study: 121 patients were treated with CT and radiotherapy (RT) (Group 1). This group was compared with a historical group of 84 patients treated by RT alone (Group 2). The CT used was Cisplatinum associated with Bleomycin and Vincristin or Vindesin and with 5 Fluoro-uracil. An objective response to CT was observed for 41% of patients. The 5 year actuarial survival rate was 19% for Group 1 and 24% for Group 2. Patterns of failure were identical in the two groups. The only difference observed was for patients with N3 nodes (26% of 5 year survival rate in Group 1 versus 9% in Group 2) (p = 0.05). The results did not depend on the histological differentiation, the tumour site or the type of CT. We conclude that this retrospective study failed to demonstrate an advantage for induction CT in oropharynx carcinoma except for patients with N3 nodes. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|